Company Overview
| Stock Name | Zhongzhipharm |
|---|---|
| Stock Code | 03737 |
| Company Full Name | To be extracted |
| Industry | Healthcare |
| Principal Activities | 我們主要於中國從事製藥及於中國廣東省中山營運連鎖藥店,開發、製造及出售中成藥及飲片(包括傳統飲片及新型飲片兩者),產品以核心品牌「中智」、「六棉牌」及「草晶華」出售。 |
| Listing Date | 2015-07-13 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國廣東省中山市火炬開發區康泰路南3號 |
| Business Address (Hong Kong) | 香港中環德輔道中141號中保集團大廈2102–2103室 |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | zeus.cn |
| Share Registrar | 联合 |
| Registrar Contact | (852)2849 3399 |
| A-Share/US Dual Listing | No |
Offering Information
| Offering Mechanism | Mechanism A |
|---|---|
| Offer Price | HK$ 2.46 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | 2015-06-30 to 2015-07-06 |
| Global Offering Shares | 200,000,000 shares |
| HK Public Offer Shares (Initial) | 20,000,000 shares (10.0%) |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | 180,000,000 shares (90.0%) |
| Offer Ratio | ~10.0% |
| Total Shares Post-IPO | 800,000,000 shares |
| Greenshoe (Over-allotment Option) | Yes |
| Stabilizing Manager (Greenshoe) | To be extracted |
| Cornerstone Share | 5.9% |
| Clawback Tiers | To be extracted |
| Reallocation Option | Yes |
| Total Global Offering Size | HK$ 492,000,000 |
Stock Connect Inclusion Analysis
| 26Q4 Regular Review | |
| Inclusion Pathway | Regular Path |
|---|---|
| HK Market Cap | HK$ 625.2M |
| Est. Threshold | HK$ 9.39B |
| Analysis Result | HK market cap below threshold, need +1402% |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | 盈利約人民幣86.7百萬元 |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
Financial Data
Unit:
'000
RMB
Income Statement
| Item | 2012 | 2013 | 2014 |
|---|---|---|---|
| Revenue | 410,052 | 482,805 | 595,565 |
| Cost of sales | -221,365 | -243,430 | -275,290 |
| Gross profit | 188,687 | 239,375 | 320,275 |
| Other income and gains, net | 7,370 | 5,383 | 6,528 |
| Selling and distribution expenses | -121,904 | -142,326 | -148,747 |
| Administrative expenses | -35,258 | -38,881 | -50,196 |
| Operating profit | 27,743 | 48,187 | 115,812 |
| Net finance costs | -4,294 | -1,384 | -1,002 |
| Profit before tax | 23,449 | 46,803 | 114,810 |
| Income tax expense | -6,195 | -9,165 | -28,122 |
| Profit for the year | 17,254 | 37,638 | 86,688 |
| Profit attributable to owners | 17,254 | 37,638 | 86,688 |
Balance Sheet
| Item | 2012 | 2013 | 2014 |
|---|---|---|---|
| Cash and cash equivalents | 25,044 | 29,077 | 58,004 |
| Trade and bills receivables | 26,806 | 28,804 | 35,489 |
| Inventories | 81,241 | 108,940 | 88,471 |
| Total current assets | 148,181 | 200,039 | 190,377 |
| Total assets | 239,621 | 298,874 | 297,924 |
| Total current liabilities | 139,537 | 157,766 | 163,631 |
| Total liabilities | 147,050 | 168,664 | 177,027 |
| Total equity | 92,571 | 130,210 | 120,897 |
| Equity attributable to owners | 92,571 | 130,210 | 120,897 |
| Interest-bearing borrowings | 25,000 | 16,000 | 15,000 |
Cash Flow Statement
| Item | 2012 | 2013 | 2014 |
|---|---|---|---|
| Net cash from operating activities | 55,539 | 44,983 | 121,637 |
| Net cash from investing activities | -5,495 | -30,567 | 5,293 |
| Net cash from financing activities | -44,010 | -10,384 | -98,002 |
| Net increase in cash | 6,034 | 4,032 | 28,928 |
| Depreciation of PP&E | 11,566 | 10,701 | 12,028 |
| Amortisation of intangible assets | 264 | 285 | 224 |
| Purchase of PP&E | -10,124 | -16,573 | -20,631 |
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
| First Day Close | HK$ 2.39 |
|---|---|
| First Day Open | HK$ 2.25 |
| First Day Change | -2.85% |
| First Day Volume | 34880000.0 |
| First Day Turnover | 80799800.0 |
| Use of Proceeds | 1、約136,000,000港元(約30%)將用于擴充公司在廣東省的連鎖藥店;
2、約90,500,000港元(約20%)將用于擴充公司的分銷網絡;
3、約90,500,000港元(約20%)將用于繼續進行公司的研發活動,其集中于新型飲片生產技術的應用及加強我們有關該方面的產品組合,以支持公司的長遠增長;
4、約90,500,000港元(約20%)將用作購買制造新型飲片之機器,并升級公司現有的生產設施;
5、約45,400,000港元(約10%)將用作營運資金及其他一般企業用途。 |
Underwriting Syndicate
Sole Sponsor (1)
Guosen Securities (HK) Capital Company Limited CE AUX600
Overall Coordinators (2)
Joint Bookrunners (3)
Joint Lead Managers (3)
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | 中融国际信托有限公司 | 116,294,040 HKD | — | 5.91% | — | 6 months | 2016-01-13 |
Directors & Management
| Position | Chinese name | English Name |
|---|---|---|
| Chairman | 賴智填 | — |
| Company Secretary | 周鳳玲 | — |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 顯智持有483,120,000股(60.39%)、智力持有42,240,000股(5.28%);賴先生及賴太太被視為控股股東,合共持有本公司上市後已發行股本約65.67%。 |
|---|




